You are viewing the site in preview mode
Skip to main content
| | |
eQTLs
|
mQTLs
|
meQTLs
|
Random SNPs
|
p-value eQTLs
|
p-value mQTLs
|
p-value meQTLs
|
p-adjusted eQTLs
|
p-adjusted mQTLs
|
p-adjusted meQTLs
|
Association
|
Name
|
|---|
| |
Total number
|
31,482
|
246,758
|
6850
|
150,000
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
–
|
|
Conservation
|
GERP
|
1049 (3.66%)
|
8112 (3.59%)
|
148 (2.35%)
|
6349 (4.65%)
|
5.04e−14
|
2.36e−55
|
8.57e−21
|
–
|
–
|
–
|
–
|
–
|
|
Siphy
|
716 (2.5%)
|
5305 (2.35%)
|
116 (1.84%)
|
3619 (2.65%)
|
1.43e−01
|
1.29e−08
|
4.42e−05
|
–
|
–
|
–
|
–
|
–
|
|
Chromatin states
|
1_TssA
|
195 (0.68%)
|
1057 (0.47%)
|
32 (0.51%)
|
222 (0.16%)
|
1.03e−43
|
8.55e−57
|
1.19e−07
|
1.74e−42
|
1.45e−55
|
2.03e−06
|
Promoter-associated
|
Active transcription start site
|
|
2_PromU
|
203 (0.71%)
|
1598 (0.71%)
|
62 (0.98%)
|
766 (0.56%)
|
3.78e−03
|
9.90e−08
|
8.23e−05
|
6.42e−02
|
1.68e−06
|
1.40e−03
|
Promoter-associated
|
Promoter upstream transcription start site
|
|
3_PromD1
|
138 (0.48%)
|
841 (0.37%)
|
68 (1.08%)
|
375 (0.27%)
|
6.39e−08
|
7.11e−07
|
5.56e−19
|
1.09e−06
|
1.21e−05
|
9.46e−18
|
Promoter-associated
|
Promoter downstream transcription start site 1
|
|
4_PromD2
|
129 (0.45%)
|
1195 (0.53%)
|
31 (0.49%)
|
300 (0.22%)
|
1.01e−10
|
5.71e−49
|
1.23e−04
|
1.72e−09
|
9.71e−48
|
2.10e−03
|
Promoter-associated
|
Promoter downstream transcription start site 2
|
|
22_PromP
|
90 (0.31%)
|
924 (0.41%)
|
29 (0.46%)
|
306 (0.22%)
|
6.32e−03
|
1.71e−21
|
6.99e−04
|
1.08e−01
|
2.91e−20
|
1.19e−02
|
Promoter-associated
|
Poised promoter
|
|
23_PromBiv
|
218 (0.76%)
|
2482 (1.1%)
|
47 (0.75%)
|
1227 (0.9%)
|
2.33e−02
|
5.59e−09
|
2.18e−01
|
3.96e−01
|
9.51e−08
|
1.00e + 00
|
Promoter-associated
|
Bivalent promoter
|
|
10_TxEnh5
|
299 (1.04%)
|
2394 (1.06%)
|
83 (1.32%)
|
542 (0.4%)
|
1.08e−36
|
4.22e−114
|
8.44e−19
|
1.83e−35
|
7.17e−113
|
1.44e−17
|
Enhancer-associated
|
Transcribed 5′preferential and enhancer
|
|
11_TxEnh3
|
417 (1.46%)
|
2332 (1.03%)
|
92 (1.46%)
|
474 (0.35%)
|
7.80e−92
|
5.23e−129
|
5.68e−27
|
1.33e−90
|
8.89e−128
|
9.66e−26
|
Enhancer-associated
|
Transcribed 3′preferential and enhancer
|
|
12_TxEnhW
|
171 (0.6%)
|
840 (0.37%)
|
21 (0.33%)
|
259 (0.19%)
|
5.81e−28
|
2.28e−23
|
1.86e−02
|
9.87e−27
|
3.87e−22
|
3.15e−01
|
enhancer-associated
|
Transcribed and weak enhancer
|
|
13_EnhA1
|
219 (0.76%)
|
1165 (0.52%)
|
111 (1.76%)
|
365 (0.27%)
|
4.68e−31
|
9.22e−31
|
1.30e−47
|
7.96e−30
|
1.57e−29
|
2.21e−46
|
Enhancer-associated
|
Active enhancer 1
|
|
14_EnhA2
|
124 (0.43%)
|
1554 (0.69%)
|
54 (0.86%)
|
388 (0.28%)
|
8.46e−05
|
6.00e−64
|
2.32e−11
|
1.44e−03
|
1.02e−62
|
3.95e−10
|
Enhancer-associated
|
Active enhancer 2
|
|
15_EnhAF
|
139 (0.49%)
|
1421 (0.63%)
|
30 (0.48%)
|
434 (0.32%)
|
3.16e−05
|
1.78e−39
|
4.04e−02
|
5.38e−04
|
3.02e−38
|
6.87e−01
|
enhancer-associated
|
Active enhancer flank
|
|
16_EnhW1
|
155 (0.54%)
|
1136 (0.5%)
|
23 (0.37%)
|
271 (0.2%)
|
7.73e−21
|
9.90e−51
|
9.47e−03
|
1.31e−19
|
1.68e−49
|
1.61e−01
|
Enhancer-associated
|
Weak enhancer 1
|
|
17_EnhW2
|
247 (0.86%)
|
1963 (0.87%)
|
26 (0.41%)
|
580 (0.43%)
|
8.48e−19
|
3.79e−58
|
1.00e + 00
|
1.44e−17
|
6.44e−57
|
1.00e + 00
|
Enhancer-associated
|
Weak enhancer 2
|
|
18_EnhAc
|
110 (0.38%)
|
767 (0.34%)
|
32 (0.51%)
|
284 (0.21%)
|
2.27e−07
|
3.67e−13
|
1.43e−05
|
3.86e−06
|
6.24e−12
|
2.43e−04
|
Enhancer-associated
|
Primary H3K27ac–possible enhancer
|
|
9_TxReg
|
129 (0.45%)
|
1274 (0.56%)
|
21 (0.33%)
|
807 (0.59%)
|
3.24e−03
|
2.97e−01
|
6.42e−03
|
5.50e−02
|
1.00e + 00
|
1.09e−01
|
Promoter/enhancer associated
|
Transcribed and regulatory
|
|
19_DNase
|
110 (0.38%)
|
948 (0.42%)
|
38 (0.6%)
|
404 (0.3%)
|
1.68e−02
|
2.31e−09
|
1.06e−04
|
2.85e−01
|
3.93e−08
|
1.80e−03
|
Promoter/enhancer associated
|
Primary DNase
|
|
Histone marks
|
H3K4me3_Pro
|
3322 (11.6%)
|
27,570 (12.21%)
|
775 (12.3%)
|
7896 (5.79%)
|
7.20e−242
|
0.00e + 00
|
2.25e−79
|
2.88e−241
|
0.00e + 00
|
9.00e−79
|
Promoter-associated
|
Histone H3 lysine 4 trimethylation
|
|
H3K9ac_Pro
|
4356 (15.21%)
|
30,036 (13.3%)
|
1207 (19.16%)
|
10,517 (7.71%)
|
7.45e−313
|
0.00e + 00
|
1.21e−175
|
2.98e−312
|
0.00e + 00
|
4.83e−175
|
Promoter-associated
|
Histone H3 lysine 9 acetylation
|
|
H3K4me1_Enh
|
3019 (10.54%)
|
22,816 (10.1%)
|
794 (12.6%)
|
5877 (4.31%)
|
0.00e + 00
|
0.00e + 00
|
7.46e−146
|
0.00e + 00
|
0.00e + 00
|
2.98e−145
|
Enhancer-associated
|
Histone H3 lysine 4 monomethylation
|
|
H3K27ac_Enh
|
5179 (18.08%)
|
43,529 (19.27%)
|
1097 (17.41%)
|
14,640 (10.73%)
|
1.83e−241
|
0.00e + 00
|
5.42e−54
|
7.31e−241
|
0.00e + 00
|
2.17e−53
|
Enhancer-associated
|
Histone H3 lysine 27 acetylation
|
|
eQTLs
|
eQTLs
|
20,199 (70.53%)
|
52,029 (23.04%)
|
5370 (85.22%)
|
6452 (4.73%)
|
0.00e + 00
|
0.00e + 00
|
0.00e + 00
|
–
|
–
|
–
|
–
|
–
|
